Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: JAMA Neurol. 2015 Feb 1;72(2):209–216. doi: 10.1001/jamaneurol.2014.2157

Table 2.

Samples Genotyped for A673T (rs63750847) by TaqMan Assaya

Characteristic Cohort
United States
Sweden
ACTb Cache County Study on Memory Health and Aging Total White Individuals Cohort 1 Cohort 2 Total Swedish Individuals
Samples, No. (A673T heterozygotes, No.)

 Cases 498 (1) 506 (0) 1004 (1) 298 (0) 564 (0) 862 (0)

 Controls 1953 (1) 3838 (1) 5791 (2) 220 (0) 487 (3) 707 (3)

 Dementia, otherc 138 (0) 383 (0) 521 (0) 0 0 0

 Total 2589 (2) 4727 (1) 7313 (3) 518 (0) 1051 (3) 1569 (3)

Male, No. (%)

 Cases 34.2 32.3 36.9 41.7

 Controls 43.5 41.7 25.0 72.1

Age, mean (SD), y

 At onset for cases 84.1 (5.6) 82.4 (6.9) 75.7 (12.9)

 At sampling for cases 76.4 (10.7)

 At last examination for controls 81.2 (7.0) 79.8 (6.3) 98.0 (1.5)

 At sampling for controls 62.7 (10.7)

Cohort type Prospective cohort Prospective cohort Case-control Case-control

Abbreviation: ACT, Adult Changes in Thought.

a

Life Technologies.

b

Includes ACT samples genotyped using the exome array and an additional 364 cases, 1344 controls, and 117 other dementias. The two A673T variants are the same as in Table 1.

c

Includes vascular dementia, mixed dementias, and other rare forms of dementia.